WinstonWınston
COLTENE Holding AG logo

COLTENE Holding AG

CLTN.SW
44
Medical - Instruments & Supplies · Healthcare
Also trades as: 0QP7.L
Price
CHF 48.20
-0.15 (-0.31%)
Market Cap
CHF 288.0M
Exchange
SIX Swiss Exchange
Winston Score
44
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 13, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Strong
Stability
Strong
Valuation
Good
Dividends
Good

Winston Score History

The full picture

COLTENE Holding AG is a Swiss company that makes dental supplies and equipment used by dentists around the world. Its core products include materials for filling teeth, cleaning root canals, taking dental impressions, and polishing teeth. The company sells primarily to dental practices, dental labs, and distributors, making it a focused player in the consumable dental supplies market.

COLTENE earns most of its revenue by selling single-use and consumable dental products that dentists reorder regularly, which creates a steady, repeat-purchase revenue stream. The company operates globally, with significant sales in North America, Europe, and Latin America, and generates roughly 300 million Swiss francs in annual revenue. Its moat comes from established brand relationships with dental professionals and a broad product portfolio, but the business faces pressure from larger competitors like Dentsply Sirona and from currency fluctuations that can hurt reported earnings since it sells worldwide but reports in Swiss francs.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 6.0M (2021) → 6.0M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
23.3%
Thin — 23.3% gross margin
Operating Margin
4.9%
Thin — 4.9% operating margin
ROCE
3.6%
Weak — 3.6% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-2.5%
Shrinking sales (-2.5% YoY)
EPS YoY
+3.3%
Modest earnings growth (+3.3% YoY)

Single-digit earnings growth — steady but not exciting.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
134%
Turns 134% of profit into real cash
FCF Margin
6.2%
Modest free cash flow (6.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.64
Moderate — manageable debt (0.64)
Interest Cover
14.24x
Comfortably covers interest (14.2x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
19.5x
Fair value — P/E 19.5

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+2.6
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
4.04%
Healthy income — 4.04% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend Growth
-9.3%
Dividend cut (-9.3% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial